Idiopathic short stature

Endocrinology and Metabolism Clinics of North America

Volumn 34, Issue 3, 2005, Pages 565-580

  Gubitosi Klug, Rose A ^a   Cuttler, Leona ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE INHIBITOR; CYTOCHROME P450; ESTROGEN; GONADORELIN AGONIST; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; LETROZOLE; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; STAT PROTEIN; TESTOSTERONE;

ARTHRALGIA; BONE DENSITY; BONE MATURATION; BRAIN PSEUDOTUMOR; BREAST CANCER; CARPAL TUNNEL SYNDROME; COLON CANCER; COUNSELING; DELAYED PUBERTY; DISEASE EXACERBATION; DRUG FATALITY; EDEMA; EPIPHYSIOLYSIS; EPIPHYSIS; FEMUR EPIPHYSIS; GENE CONTROL; GENE MUTATION; GENETIC HETEROGENEITY; GYNECOMASTIA; HEALTH CARE MANAGEMENT; HORMONAL THERAPY; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE RESISTANCE; HORMONE RESPONSE; HUMAN; HYPERINSULINISM; IDIOPATHIC DISEASE; IDIOPATHIC SHORT STATURE; MEDICAL DECISION MAKING; NEVUS; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY TRACT DISEASE; REVIEW; SCOLIOSIS; SHORT STATURE; SIDE EFFECT; TREATMENT OUTCOME;

BODY HEIGHT; GROWTH DISORDERS; HUMANS;

EID: 23444451084     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2005.04.003     Document Type: Review

References (49)

1. M. Freemark Editorial. Growth hormone treatment of idiopathic short stature: not so fast J Clin Endocrinol Metab 89 7 2004 3138 3139
2. L. Cuttler, and J.B. Silvers Growth hormone treatment for idiopathic short stature: implications for practice and policy Arch Pediatr Adolesc Med 158 2 2004 108 110
3. T.A. Wilson, S.R. Rose, and P. Cohen Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee J Pediatr 143 4 2003 415 421
4. L. Wilkins The diagnosis and treatment of endocrine disorders in childhood and adolescence 1950 Charles C. Thomas Baltimore (MD)
5. R. Lindsay, M. Feldkamp, and D. Harris Utah Growth Study: growth standards and the prevalence of growth hormone deficiency J Pediatr 125 1 1994 29 35
6. M.B. Ranke Towards a consensus on the definition of idiopathic short stature Horm Res 45 Suppl 2 1996 64 66
7. A.M. Pasquino, A. Albanese, and M. Bozzola Idiopathic short stature J Pediatr Endocrinol Metab 14 Suppl 2 2001 967 974
8. K.M. Attie Genetic studies in idiopathic short stature Curr Opin Pediatr 12 4 2000 400 404
9. L.A. Metherell, S.A. Akker, and P.B. Munroe Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity Am J Hum Genet 69 3 2001 641 646
10. J.E. Sanchez, E. Perera, and L. Baumbach Growth hormone receptor mutations in children with idiopathic short stature J Clin Endocrinol Metab 83 11 1998 4079 4083
11. K.A. Woods, F. Dastot, and M.A. Preece Phenotype: genotype relationships in growth hormone insensitivity syndrome J Clin Endocrinol Metab 82 11 1997 3529 3535
12. A.D. Goddard, P. Dowd, and S. Chernausek Partial growth hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature J Pediatr 131 1997 S51 S55
13. A. Milward, L. Metherell, and M. Maamra Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction J Clin Endocrinol Metab 89 3 2004 1259 1266
14. E.M. Kofoed, V. Hwa, and B. Little Growth hormone insensitivity associated with a STAT5b mutation N Engl J Med 349 12 2003 1139 1147
15. K.A. Woods, C. Camacho-Hubner, and M.O. Savage Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene N Engl J Med 335 18 1996 1363 1367
16. J. Abuzzahab, A. Schneider, and A. Goddard IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation N Engl J Med 349 23 2003 2211 2222
17. M.D. Lewis, M. Horan, and D.S. Millar A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway J Clin Endocrinol Metab 89 3 2004 1068 1075
18. Y. Takahashi, H. Kaji, and Y. Okimura Short stature caused by a mutant growth hormone with an antagonistic effect Endocr J 43 1996 S27 S32
19. Y. Takahashi, H. Shirono, and O. Arisaka Biologically inactive growth hormone caused by an amino acid substitution J Clin Invest 100 5 1997 1159 1165
20. P.C. Hindmarsh Commentary. Standard and low-dose IGF-1 generation tests and spontaneous growth hormone secretion in children with idiopathic short stature Clin Endocrinol (Oxf) 60 2004 161 162
21. J. Blair, C. Camacho-Hubner, and F. Miraki Moud Standard and low-dose IGF-1 generation tests and spontaneous growth hormone secretion in children with idiopathic short stature Clin Endocrinol (Oxf) 60 2004 163 168
22. P. Grupposo The clinical laboratory evaluation of GH responsiveness J Clin Endocrinol Metab 87 2 2002 466 468
23. E. Rao, B. Weiss, and M. Fukami Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome Nat Genet 16 1 1997 54 63
24. G. Binder, C. Schwarze, and M.B. Ranke Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone J Clin Endocrinol Metab 85 2000 245 249
25. G.A. Rappold, M. Fukami, and B. Niesler Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature J Clin Endocrinol Metab 87 2002 1402 1406
26. G. Binder, M.B. Ranke, and D. Martin Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature J Clin Endocrinol Metab 88 10 2003 4891 4896
27. J.M. Wit, G.A. Kamp, and B. Rikken Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature Pediatr Res 39 2 1996 295 302
28. J. Bramswig, M. Fasse, and M. Holthoff Adult height in boys and girls with untreated short stature and constitutional delay of growth and puberty: accuracy of five different methods of height prediction J Pediatr 117 6 1990 886 891
29. G.D. Zimet, R. Owens, and W. Dahms Psychosocial outcome of children evaluated for short stature Arch Pediatr Adolesc Med 151 10 1997 1017 1023
30. N.C. Theunissen, G.A. Kamp, and H.M. Koopman Quality of life and self-esteem in children treated for idiopathic short stature J Pediatr 140 5 2002 507 515
31. D.J. Radcliffe, J.S. Pliskin, and J.B. Silvers Growth hormone therapy and quality of life in adults and children Pharmacoeconomics 22 8 2004 499 524
32. D.E. Sandberg, W.M. Bukowski, and C.M. Fung Height and social adjustment: are extremes a cause for concern and action? Pediatrics 114 3 2004 744 750
33. N. Persico, A. Postlewaite, and D. Silverman The effect of adolescent experience on labor market outcomes: the case of height. Working paper number 03-036 2003 Penn Institute for Economic Research Philadelphia
34. M.M. Grumbach Growth hormone therapy and the short end of the stick N Engl J Med 319 1988 238 241
35. Rosenfield RL, Cuttler L. Growth and maturation. In: DeGroot LJL, editor. Endocrinology. Philadelphia: WB Saunders; 2006, in press.
36. J.A. Yanovski, S.R. Rose, and G. Municchi Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature N Engl J Med 348 10 2003 908 917
37. G.A. Kamp, D. Mul, and J.J. Waelkens A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation J Clin Endocrinol Metab 86 7 2001 2969 2975
38. S. Wickman, I. Sipila, and C. Ankarberg-Lindgren A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial Lancet 357 9270 2001 1743 1748
39. FDA. FDA talk paper: FDA approves humatrope for short stature. Available at: http://www.fda.gov. Accessed August 23, 2003.
40. B.S. Finkelstein, T.F. Imperiale, and T. Speroff Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis Arch Pediatr Adolesc Med 156 3 2002 230 240
41. J. Bryant, C. Cave, and R. Milne Recombinant growth hormone for idiopathic short stature in children and adolescents Cochrane Database Syst Rev 4 2003 CD004440
42. E.W. Leschek, S.R. Rose, and J.A. Yanovski Effect of growth hormone treatment on adult height in prepubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial J Clin Endocrinol Metab 89 7 2004 3140 3148
43. J.M. Wit, and L.T. Rekers-Mombarg Final height gain by GH therapy in children with idiopathic short stature is dose dependent J Clin Endocrinol Metab 87 2 2002 604 611
44. A. Downie, J. Mulligan, and E. McCaughey Psychological response to growth hormone treatment in short normal children Arch Dis Child 75 1 1996 32 35
45. C. Dos Santos, L. Essioux, and C. Teinturier A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone Nat Genet 36 7 2004 720 724
46. L. Voss Short normal stature and psychosocial disadvantage: a critical review of the evidence J Pediatr Endocrinol Metab 14 6 2001 701 711
47. J. Lantos, M. Siegler, and L. Cuttler Ethical dilemmas in growth hormone therapy JAMA 261 1989 1020 1024
48. L. Cuttler, J.B. Silvers, and D. Neuhauser Physician management of short stature in childhood: a national study of physician recommendation patterns JAMA 276 7 1996 531 537
49. B. Finkelstein, J.B. Silvers, and D. Neuhauser Insurance coverage, physician recommendations, and access to emerging treatments: growth hormone therapy for childhood short stature JAMA 279 1998 663 668